Data for ST000675   

(Analysis AN001036): Average values per metabolite and experimental factor (Units:Peak area normalized)

Metabolite structureAll dataF1F2
CL 78:3; [M-2H](2-)@7.45
10998.11 15102.07
FFA(16:0)
16540687.14 18584318.08
FFA(18:0)
19632439.12 20762111.47
FFA(18:1)
13447815.25 19835379.68
FFA(18:2)
3355842.53 5068194.59
FFA(20:0)
421357.96 495432.11
FFA(20:1)
519247.63 995140.61
FFA(20:2)
212493.48 392718.44
FFA(20:4) Arachidonic acid
610807.46 511304.10
FFA(22:0)
171925.56 195159.33
FFA(22:1)
61781.54 85824.15
FFA(22:2)
22211.96 39895.95
FFA(22:3)
16458.64 32595.37
FFA(24:0)
99458.85 116357.89
FFA(24:1)
83449.20 113613.77
FFA(24:2)
30796.10 39533.24
FFA(24:3)
3267.11 3688.84
lysoPE 18:0; [M-H]-@2.40
9650.61 15649.17
lysoPE 18:1; [M-H]-@1.78
12466.76 15595.17
lysoPE 18:2; [M-H]-@1.29
13956.74 15309.27
lysoPE 20:4; [M-H]-@1.28
17584.73 16695.76
lysoPE 22:5; [M-H]-@1.49
1948.62 2693.75
PA 34:2; [M-H]-@6.18
4022.61 3583.31
PC 28:0; [M-Ac-H]-@5.15
5913.52 6997.16
PC 30:0; [M-Ac-H]-@5.87
24707.27 31300.30
PC 30:1; [M-Ac-H]-@5.32
11536.66 19397.07
PC 31:0; [M-Ac-H]-@6.14
10545.51 11536.08
PC 32:0; [M-Ac-H]-@6.49
107963.22 116571.17
PC 32:1; [M-Ac-H]-@5.98
110841.04 157629.96
PC 32:2; [M-Ac-H]-@5.48
59150.78 78524.19
PC 33:1; [M-Ac-H]-@6.33
28113.50 30586.65
PC 33:2; [M-Ac-H]-@5.86
31182.67 32951.19
PC 34:1; [M-Ac-H]-@6.58
477020.38 536423.12
PC 34:2; [M-Ac-H]-@6.13
425777.40 535264.86
PC 34:3; [M-Ac-H]-@5.66
70795.85 104836.04
PC 35:1; [M-Ac-H]-@6.91
13164.08 15038.14
PC 35:2; [M-Ac-H]-@6.46
18038.84 24330.82
PC 35:3; [M-Ac-H]-@6.01
12573.20 17970.06
PC 36:1; [M-Ac-H]-@7.19
88518.04 92184.60
PC 36:2; [M-Ac-H]-@6.72
228691.01 290080.00
PC 36:3; [M-Ac-H]-@6.29
164435.12 223266.76
PC 36:4; [M-Ac-H]-@6.02
77311.60 93573.75
PC 36:5; [M-Ac-H]-@5.57
18885.21 32947.60
PC 37:4; [M-Ac-H]-@6.42
5597.32 9600.26
PC 38:2; [M-Ac-H]-@7.30
10970.37 16725.39
PC 38:3; [M-Ac-H]-@6.95
23206.09 32190.09
PC 38:4; [M-Ac-H]-@6.68
53655.54 66029.76
PC 38:5; [M-Ac-H]-@6.26
45872.67 59727.86
PC 38:7; [M-Ac-H]-@5.45
2482.37 5323.80
PC 40:4; [M-Ac-H]-@7.19
3964.85 5071.66
PC 40:5; [M-Ac-H]-@6.97
6418.72 9880.66
PC 40:7; [M-Ac-H]-@6.11
2598.63 5711.24
PC 40:8; [M-Ac-H]-@5.70
15789.47 16579.89
PE 30:0; [M-H]-@6.02
2781.60 4295.14
PE 32:2; [M-H]-@5.64
6351.15 9905.54
PE 34:1; [M-H]-@6.76
79789.65 116363.44
PE 34:2; [M-H]-@6.31
138442.55 166806.42
PE 34:3; [M-H]-@5.87
56930.00 87929.63
PE 35:1; [M-H]-@7.07
3255.35 3975.39
PE 35:2; [M-H]-@6.58
8499.15 10651.68
PE 35:4; [M-H]-@5.98
3124.31 2627.99
PE 36:1; [M-H]-@6.79
19100.86 23349.11
PE 36:1; [M-H]-@7.35
108345.75 153012.20
PE 36:2; [M-H]-@5.99
9020.53 16575.10
PE 36:3; [M-H]-@6.48
128037.51 167463.71
PE 36:5; [M-H]-@5.90
35246.92 50303.70
PE 37:4; [M-H]-@6.62
4811.61 7128.06
PE 38:1; [M-H]-@7.84
4519.42 6803.25
PE 38:3; [M-H]-@7.17
38354.63 37383.46
PE 38:4; [M-H]-@6.89
175848.78 209591.22
PE 40:1; [M-H]-@8.32
3272.44 3688.17
PE 40:2; [M-H]-@7.88
3702.99 6440.09
PE 40:5; [M-H]-@6.91
16293.57 20574.98
PE 40:6; [M-H]-@6.85
21107.27 26452.59
PE 40:7; [M-H]-@6.33
18203.78 24056.76
PG 32:1; [M-H]-@5.36
2443.87 4265.59
PG 33:0; [M-H]-@6.15
2711.14 4948.27
PG 34:1; [M-H]-@5.91
122225.22 189263.66
PG 34:2; [M-H]-@5.32
5089.64 9932.45
PG 36:0; [M-H]-@6.97
42863.15 51592.88
PG 36:1; [M-H]-@6.55
22896.65 33869.40
PG 36:2; [M-H]-@6.02
44148.23 68369.46
PG 36:3; [M-H]-@5.39
16536.10 23081.74
PG 38:3; [M-H]-@5.91
8539.01 11343.41
PG 38:4; [M-H]-@5.51
3454.04 5310.38
PG 40:5; [M-H]-@5.75
4532.76 5130.11
PI 32:1; [M-H]-@5.15
2871.01 4810.38
PI 34:1; [M-H]-@5.81
16635.82 20923.23
PI 34:2; [M-H]-@5.32
8806.88 13203.77
PI 36:2; [M-H]-@5.94
124418.07 202195.79
PI 36:3; [M-H]-@5.48
12468.71 18458.78
PI 36:4; [M-H]-@5.36
16665.94 21854.56
PI 38:4; [M-H]-@5.94
824258.26 1272735.57
PI 38:5; [M-H]-@5.47
22935.88 35799.41
PI 40:5; [M-H]-@6.02
8397.03 11155.28
plasmenyl-PE 33:1; [M-H]-@6.83
3491.89 5194.38
plasmenyl-PE 34:2; [M-H]-@6.63
178644.50 247662.95
plasmenyl-PE 34:3; [M-H]-@6.24
13878.27 17313.73
plasmenyl-PE 36:2; [M-H]-@6.50
14019.50 17334.72
plasmenyl-PE 36:3; [M-H]-@6.78
197789.24 239727.28
plasmenyl-PE 38:1; [M-H]-@8.10
7203.34 8401.68
plasmenyl-PE 38:2; [M-H]-@7.71
17646.61 24410.12
plasmenyl-PE 40:5; [M-H]-@7.29
69057.64 88090.49
PS 32:1; [M-H]-@5.26
10944.19 12841.59
PS 34:1; [M-H]-@5.88
58194.66 89855.97
PS 34:2; [M-H]-@5.44
25574.95 35460.75
PS 36:1; [M-H]-@6.53
119892.20 164958.43
PS 36:2; [M-H]-@6.02
98653.31 167555.21
PS 36:3; [M-H]-@5.64
15899.84 26903.15
PS 36:4; [M-H]-@5.42
4267.48 5808.35
PS 38:3; [M-H]-@6.29
18122.67 24080.41
PS 38:4; [M-H]-@6.06
24864.96 39999.44
PS 38:5; [M-H]-@5.59
5458.74 9554.50
PS 38:6; [M-H]-@5.33
3271.00 4011.25
PS 40:2; [M-H]-@7.26
3756.57 5496.04
PS 40:4; [M-H]-@6.48
10505.04 13535.91
PS 40:5; [M-H]-@6.15
11803.28 17691.43
PS 40:6; [M-H]-@5.97
10943.33 15345.68

Factors:

F1TYPE:control
F2TYPE:Rosi
  logo